menu
    • menu

    Company profile for Par Health

    NEW Drugs in Dev: 1
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Par Health brings together the legacies of Mallinckrodt and Endo, combining over a century of experience in essential medicines. Its manufacturing network centers on the historic API site in St. Louis and the Rochester facility, recognized for the first FDA Biologics license for polio vaccine production, alongside eight additional sites in the US and India. This global footprint supports consistent, high-quality manufacturing ...
    Par Health brings together the legacies of Mallinckrodt and Endo, combining over a century of experience in essential medicines. Its manufacturing network centers on the historic API site in St. Louis and the Rochester facility, recognized for the first FDA Biologics license for polio vaccine production, alongside eight additional sites in the US and India. This global footprint supports consistent, high-quality manufacturing and a longstanding commitment to precision, reliability, and elevated standards in medicine supply.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Par HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    675 James S. McDonnell Blvd Saint Louis, MO 63042
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.parhealth.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    UCSF, Par Health Hit With FDA Environmental Warnings
    UCSF, Par Health Hit With FDA Environmental Warnings

    27 Apr 2026

    // BIOSPACE

    https://www.biospace.com/fda/ucsf-par-health-hit-with-fda-warning-letters-for-environmental-monitoring-issues

    BIOSPACE
    27 Apr 2026
    Share Share
    Par Health’s Receives FDA Warning Letter
    Par Health’s Receives FDA Warning Letter

    21 Apr 2026

    // FDA

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/par-health-usa-llc-endo-usa-inc-722121-04152026

    FDA
    21 Apr 2026
    Share Share
    Mallinckrodt Spins Off Par Health, Launches Keenova Therapeutics
    Mallinckrodt Spins Off Par Health, Launches Keenova Therapeutics

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-completes-spin-off-of-par-health-introduces-keenova-therapeutics-302610045.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Par Health Reveals Q3 2025 Financials And Business Update
    Par Health Reveals Q3 2025 Financials And Business Update

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/par-health-reports-third-quarter-2025-financial-results-and-provides-business-update-302609774.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search